Full Press Release Details
Amgen's Investigational Targeted Treatment Bemarituzumab Granted Breakthrough Therapy Designation.
ZLAB
Amgen's Investigational Targeted Treatment Bemarituzumab Granted Breakthrough Therapy Designation
Key Takeaway: Amgen's Investigational Targeted Treatment Bemarituzumab Granted Breakthrough Therapy Designation